alexa Cedrik M. Britten | GlaxoSmithKline Deutschland
ISSN: 1745-7580

Immunome Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Cedrik M. Britten

Cedrik M. Britten Head
Cellular Therapy-Immuno-oncology
GlaxoSmithKline Deutschland
Germany
 
Biography

Dr. Cedrik M. Britten is the Head Cellular Therapy-Immuno-oncology at GlaxoSmithKline Deutschland (GSK), Germany. He completed his Doctor of Medicine (M.D.) from University Medical Center of the Johannes-Gutenberg University in the year 2001.

Research Interest

His research interest includes Immunology, Cell Culture, Molecular Biology and Cancer.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords